{"name":"XWPharma","slug":"xwpharma","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[],"pipeline":[],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMiygFBVV95cUxNTEJyLVB0Nkg0dS01b2VnaC1NQlhwUzdUbjJFanF0WDZGZzR6S0hFcUZfYzRaZ1pVWUUxUklxTF84ZnEyTmFBU2RPU2dZbWRvMENRTFBfSFJHOXZyckxybVNoTGNyckdnaW5Ca2VlS2s3S3FaQTUzaFhmdHRMTmFwbVRjM2ZjM0E2WUt6WlVJX2o5b2sxWEd2XzZ6SHZzRnhkZE9MZlIyZkp1SW9yclNLVUJNT0pnQ3VBRVB3YW96N2VxVFo4aW81aFVB?oc=5","date":"2025-11-23","type":"trial","source":"Genetic Engineering and Biotechnology News","summary":"StockWatch: Avadel Sparks Bidding War; Agios Plummets 51% on Phase III Data - Genetic Engineering and Biotechnology News","headline":"StockWatch: Avadel Sparks Bidding War; Agios Plummets 51% on Phase III Data","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMizwFBVV95cUxOYzExUlpBX2VhTDVSdFB2MG9qamJYdjZUT2Y3MUxSYjZiTXJ3TkE5aHM2NDNsRTB3ekllMm1rVXFUTlRuZzN2VndzWEhPZ0U0dXRRdE00QlcyQmlnMTRfVEo3VFV6RUYtWlRhVThhNHhsa2t1SUlWU3BYTkRHM2JOeGozOGl0M3RaTFlVTUZrVEtTTXJ5V3dCVExRUUwtcUpBRWZyTklFMGd1ZzVxOExQWmRWa2pBcFpId19aRUs0aVRjbkUxX1pDZDhIUGhGTVk?oc=5","date":"2025-10-22","type":"deal","source":"Investing.com","summary":"Jefferies downgrades Avadel Pharmaceuticals stock to Hold on Alkermes deal - Investing.com","headline":"Jefferies downgrades Avadel Pharmaceuticals stock to Hold on Alkermes deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMijwFBVV95cUxPby1SR210NFJISXpGRnBIT3FyLVl3b0ptaU42cDJiNVNSbmZrU1lyZl9zc1g5WDhJWXdvWnVGbnRDMUkxT052cHMyUUVhai1obWdFSVRsNEYwdElPenpqcFhmeW5uY21PM0ZvRGpDVE1YT2ZEeHplTEk4cmZPVGlIbU9NeEdIcHFhYUlFeDR2MA?oc=5","date":"2025-09-04","type":"deal","source":"Pharmaceutical Executive","summary":"Avadel Partners with XWPharma to Commercialize Sleep Medication - Pharmaceutical Executive","headline":"Avadel Partners with XWPharma to Commercialize Sleep Medication","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMif0FVX3lxTE9XWFpRYkdSMUtkOXJtVzV1OXVrSzg3X1JNWU1PZ1JHa1RmNjhDVFo3MGVudVZ1VTRWZjUyUWhKSHh6aXZzOU9vMmFWeDlBR1AxY3ZpdkRjWk9UWXd0NkM0cWc5X3Q4VE9jTl91Z3BYUTVwZXVyWWhZbXBfUmo2QmM?oc=5","date":"2025-09-04","type":"pipeline","source":"Pharmaceutical Technology","summary":"Avadel secures rights to develop valiloxybate globally - Pharmaceutical Technology","headline":"Avadel secures rights to develop valiloxybate globally","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi4wFBVV95cUxPMkZoRXh3WENqdVBaZWowRGJvai1sM1lEbkU3M3RUYzg1bW9mR2VPSkJma1Z1MWc4anhpMWw2dFU3RmNmWXdNUUVZcjJGZld5ZTRydWJYVS1STFFSeWV2c0o0cXFzcHd4WUZWX3IyTVR1OEFwSTVSWkprWDRGbzVPdzRJTDNWb19uTUU2Tk5jTE5kNlBFbU5oV1FBMWhOc3EtRzkwTGgwNkZ4TzhVaUpTbnMxSFd0OTZ5d0dzZ2w0TUtaQUV2ZVpSZjNuNGZURVY0M2dDRlRTZnV4aUdESmJ4UUVpOA?oc=5","date":"2025-09-04","type":"pipeline","source":"Sleep Review","summary":"The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH - Sleep Review","headline":"The Once-Nightly, Salt-Free, Artificial Sweetener-Free Oxybate in the Works for Narcolepsy, IH","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirAJBVV95cUxNeDdqQ05ZcVhNR3FNSGg0TnR6UHJhckRJTnhPbmdkV0xUZWhiRjdmZUREdnlhbjRsZTJVaEdwUHVBMmp5N3lMckZqVVd2ZkxWX3pYOUpqdTUwUGlFRGxpcndPd1JpeTZ1dUJEbm16RlRMTmNCdk5jODFCNG1QOFRzNi1vVm9oMUhoVFJlSkc3UlI1cVdsMWxxdzBGeTFxN2F1eVVJbURHQU04SEdRSzVsS3k1UFVLc2dmQzJyRko4RlVrNW9jTTVBeXhObWhFUTRJTEtKTy1wQVJvTGpvVklqNm5jQU9qdkNSbWJKc0FHdFZlcXMtdHotdUt6ZG9hcEluWEN6YWx5cFg4bTh2TkdJRFhMWjBTMkc0c1pNX2l1Y1daU3BicnJLRWtBdjA?oc=5","date":"2023-04-19","type":"trial","source":"prnewswire.com","summary":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Working in the Domain | DelveInsight - prnewswire.com","headline":"Parkinson's Disease Clinical Trial Pipeline Space Brims With Novel Emerging Therapies with Over 120 Key Companies Workin","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi6gFBVV95cUxNSnc5MVhESUVWMnNMQkY0NFNlT09GTUx2T0hacG0tUEF0UlV5SnY3QUhsUlpWTkhScU9OQUM0U3RqYXdpREJaY1VTdndfUkFEUEx0OVkyVjhSS2IwZkxYbzk5akIzc3hmNFN3TURFOGZZYm9CWS0yaDlWSWdQSlk2UXFTVUNmbTNYZnkyLXdWdG9DXzNRMzB2d2tDOFJ4UF93VXg1NTlwZ0pNeThvZnpFd2FiUmhXdFVzYWt2LXA0MXB6cHNKaDBFZXR1OVRDNjdpdDdTRklVNkdHM2MybTlHdVBma2xYMHJvQkE?oc=5","date":"2021-10-19","type":"pipeline","source":"Healthcare Radius","summary":"XWPharma initiates first-in-human studies of XW10508, in development for fast-acting relief of treatment-resistant depression and chronic pain - Healthcare Radius","headline":"XWPharma initiates first-in-human studies of XW10508, in development for fast-acting relief of treatment-resistant depre","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi9wFBVV95cUxPb3VXZ1NGemUwVGNRSFpjVTRzV0FQUjVqeHFiY05wa0Z6Y2k0SWhIbHQzb1lnb3ppWXQ3RHpSTUNySG9Cc2VSM1Z2eS1uanpueFRUS3hId2VZU3Z5dU9hVmNjOGNWOWhPT0FOWUdId082UXo5MUQzcjdfUVE0am1PS3gxbk5SOHVYMlBPdmk4blNDR1N2cUJGV19mM2lYVGN4WDlHTzZJNDQyTW80Z0g4VkJMLUFEOVF2dUFKWEtWbWRwOWcyQlA5Y2NRODNUbU8ySWl1bGRiZEV0TzNJNGdaNFZ5azQyZ184QnpOZFlGVHM2a0djeVdv?oc=5","date":"2020-09-17","type":"pipeline","source":"GlobeNewswire","summary":"XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer - GlobeNewswire","headline":"XWPharma Announces $40 Million Financing and Appoints Leonard Blum as Chief Executive Officer","sentiment":"neutral"}],"patents":[],"drugCount":0,"phaseCounts":{},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}